Search results
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via AOL· 4 days agoModerna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...
Leaked Video of Mark Zuckerberg Discussing Vaccines Omits Context
Snopes via Yahoo News· 5 days agoMore importantly, this clip lacked context. At the time, Zuckerberg lacked a proper understanding of...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 4 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
Could Novavax Become the Next Moderna?
The Motley Fool via AOL· 5 days agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 1 day agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 4 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 5 days agoNovavax (NVAX -9.65%) and Moderna (MRNA 0.17%) both entered the coronavirus vaccine race around the...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 4 days agoStocks recently featured in the blog include: Novavax, Inc. NVAX, Sanofi SNY, Fulcrum Therapeutics,...
AstraZeneca aims increase its annual revenue by 75% in its post-COVID era
Quartz· 8 hours agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19 vaccines off the shelves. AstraZeneca announced ...
Moderna (NASDAQ:MRNA) Upgraded to Hold by Evercore ISI
ETF DAILY NEWS· 6 days agoEvercore ISI upgraded shares of Moderna (NASDAQ:MRNA – Free Report) to a hold rating in a research note released on Monday, Zacks.com reports. Canaccord Genuity Group lifted ...